104 results on '"Beijk, Marcel A.M."'
Search Results
2. Comparison of the Diagnostic Yield of Intracoronary Acetylcholine Infusion and Acetylcholine Bolus Injection Protocols During Invasive Coronary Function Testing
3. Higher Edmonton Frail Scale prior to transcatheter Aortic Valve Implantation is related to longer hospital stay and mortality
4. Prognostic Implications of Individual and Combinations of Resting and Hyperemic Coronary Pressure and Flow Parameters
5. Sex differences in prevalence and outcomes of the different endotypes of chronic coronary syndrome in symptomatic patients undergoing invasive coronary angiography: Insights from the global ILIAS invasive coronary physiology registry
6. Myocardial Bridging as a Trigger in Angina With No Obstructive Coronary Artery Disease
7. Post-spastic flow recovery time to document vasospasm induced ischemia during acetylcholine provocation testing
8. Efficacy and safety of the endothelin-1 receptor antagonist macitentan in epicardial and microvascular vasospasm; a proof-of-concept study
9. Reference values for intracoronary Doppler flow velocity-derived hyperaemic microvascular resistance index
10. Long-Term Performance of the COMBO Dual-Therapy Stent: Results from the REMEDEE Registry
11. Pulmonary vascular imaging characteristics after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension
12. Higher Edmonton Frail Scale prior to transcatheter Aortic Valve Implantation is related to longer hospital stay and mortality
13. The Effect of Nitroglycerin in Diagnostic Endotypes of Coronary Vasospasm
14. A 2-Stent Strategy in Complex Bifurcation Lesions: A Matter of Single or Double Kissing Balloon Inflation?
15. Single antiplatelet therapy directly after percutaneous coronary intervention in non-ST-segment elevation acute coronary syndrome patients
16. Early discontinuation of dual antiplatelet therapy in patients treated with the bio-engineered pro-healing sirolimus-eluting (COMBO) stent
17. Practical Approach for Angina and Non-Obstructive Coronary Arteries: A State-of-the-Art Review
18. Atrial Right-to-Left Shunting Does Not Predict PFO Orifice Area in Patients Undergoing Percutaneous PFO Closure
19. Haemodynamic characterisation of different endotypes in coronary artery vasospasm in reaction to acetylcholine
20. Presence of Coronary Endothelial Dysfunction, Coronary Vasospasm, and Adenosine-Mediated Vasodilatory Disorders in Patients With Ischemia and Nonobstructive Coronary Arteries
21. Comparison of Doppler Flow Velocity and Thermodilution Derived Indexes of Coronary Physiology
22. CT Derived Anatomy Predicts Complexity and Hemodynamic Impact of Transcatheter Edge-to-Edge Mitral Valve Repair
23. CT Imaging-Derived Anatomy Predicts Complexity and Hemodynamic Impact of Transcatheter Edge-to-Edge Mitral Valve Repair
24. Transradial access in chronic anticoagulated patients: One step closer to a “radial-first” strategy in all patients
25. Acetylcholine Rechallenge
26. Respiration‐related variations in Pd/Pa ratio and fractional flow reserve in resting conditions and during intravenous adenosine administration
27. Final five‐year results of the REMEDEE Registry: Real‐world experience with the dual‐therapy COMBO stent
28. Clinical Outcomes After Bare-Metal Stenting in Diabetic Patients With Lesions Carrying a Low Risk of Restenosis
29. Respiration‐related variations in Pd/Pa ratio and fractional flow reserve in resting conditions and during intravenous adenosine administration.
30. Three-Year Clinical Follow-Up of an Unselected Patient Population Treated with the Genous Endothelial Progenitor Cell Capturing Stent
31. Two-year follow-up of the genous™ endothelial progenitor cell capturing stent versus the taxus liberté stent in patients with De Novo coronary artery lesions with a high-risk of restenosis†
32. One-Year Clinical Outcome in an Unselected Patient Population Treated With the Genous™ Endothelial Progenitor Cell Capturing Stent
33. Genous™ endothelial progenitor cell capturing stent vs. the Taxus Liberté stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study
34. Final five‐year results of the REMEDEE Registry: Real‐world experience with the dual‐therapy COMBO stent.
35. Design and rationale of the TRI-stent Adjudication Study (TRIAS) Program
36. Clinical outcomes at 2 years of the Absorb bioresorbable vascular scaffold versus the Xience drug‐eluting metallic stent in patients presenting with acute coronary syndrome versus stable coronary disease—AIDA trial substudy
37. 500.02 Clinical Outcomes At 2 Years of The Absorb Bioresorbable Vascular Scaffold Versus The Xience Drug-eluting Metallic Stent In Patients Presenting With Acute Coronary Syndrome Versus Stable Coronary Disease - Aida Trial Sub-study.
38. Clinical outcomes at 2 years of the Absorb bioresorbable vascular scaffold versus the Xience drug‐eluting metallic stent in patients presenting with acute coronary syndrome versus stable coronary disease—AIDA trial substudy.
39. Tissue-derived circulating miRNAs can identify atherosclerosis and plaque instability
40. Evaluation of clinical outcomes after COMBO stent treatment in patients presenting with acute coronary syndrome
41. Significant intimal hyperplasia regression between 6 and 18 months following Genous™ endothelial progenitor cell capturing stent placement
42. Evaluation of clinical outcomes after C OMBO stent treatment in patients presenting with acute coronary syndrome.
43. Clinical outcomes after bare-metal stenting in diabetic patients with lesions carrying a low risk of restenosis
44. Differences in cardiovascular risk factors and clinical outcomes between Western European and Southeast Asian patients treated with the Genous Bio-engineered R stent
45. Assessment of renal sympathetic control using invasive pressure and flow velocity measurements in humans
46. A retrospective analysis of consecutive patients undergoing nonurgent percutaneous coronary intervention comparing bare metal stents with drug-eluting stents using the National Institute for Clinical Excellence criteria
47. Multiple Biomarkers at Admission Significantly Improve the Prediction of Mortality in Patients Undergoing Primary Percutaneous Coronary Intervention for Acute ST-Segment Elevation Myocardial Infarction
48. One-year clinical outcome after provisional T-stenting for bifurcation lesions with the endothelial progenitor cell capturing stent compared with the bare-metal stent
49. Toll-like receptor 4 gene polymorphisms show no association with the risk of clinical or angiographic restenosis after percutaneous coronary intervention
50. Long‐term follow‐up after nonurgent percutaneous coronary intervention in unprotected left main coronary arteries
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.